雜志介紹

Oncology-new York雜志介紹

《Oncology-new York》是一本以(yi)(yi)English為主(zhu)的未開放獲取國際(ji)優(you)秀期刊，中文(wen)名稱腫瘤(liu)學-紐約(yue)，本刊主(zhu)要出版、報(bao)道(dao)醫學-ONCOLOGY領域的研(yan)(yan)究動(dong)態(tai)以(yi)(yi)及(ji)在該(gai)領域取得(de)的各方面的經驗和科研(yan)(yan)成果，介紹該(gai)領域有關(guan)本專業(ye)(ye)的最新進(jin)展，探(tan)討行(xing)業(ye)(ye)發展的思路(lu)和方法，以(yi)(yi)促進(jin)學術信息(xi)交流，提高行(xing)業(ye)(ye)發展。該(gai)刊已(yi)被國際(ji)權(quan)威數據庫SCIE收(shou)錄，為該(gai)領域相關(guan)學科的發展起到了(le)良好的推動(dong)作用，也得(de)到了(le)本專業(ye)(ye)人員的廣泛認可。該(gai)刊最新影響(xiang)因子(zi)為1.8，最新CiteScore 指數為1.6。

英文介紹

Oncology-new York雜志英文介紹

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.